Literature DB >> 17196918

Traffic signal phasing at intersections to improve safety for alcohol-affected pedestrians.

Michael G Lenné1, Bruce F Corben, Karen Stephan.   

Abstract

Alcohol-affected pedestrians are among the highest-risk groups involved in pedestrian casualty crashes. This paper investigates the opportunities to use a modified form of traffic signal operation during high-risk periods and at high-risk locations to reduce alcohol-affected pedestrian crashes and the severity of injuries that might otherwise occur. The 'Dwell-on-Red' treatment involves displaying a red traffic signal to all vehicle directions during periods when no vehicular traffic is detected, so that drivers approach high-risk intersections at a lower speed than if a green signal were displayed. Vehicle speed data were collected before and after treatment activation at both a control and treatment site. Speed data were collected both 30 m prior to and at the intersection stop line. The treatment was associated with a reduction in mean vehicle speeds of 3.9 kph (9%) and 11.0 kph (28%) at 30 m and stop line collection points, respectively, and substantial reductions in the proportion of vehicles travelling at threatening speeds with regard to the severity of pedestrian injury. Other important road safety concerns may also benefit from this form of traffic signal modification, and it is recommended that other areas of application be explored, including the other severe trauma categories typically concentrated around signalised intersections.

Entities:  

Mesh:

Year:  2007        PMID: 17196918     DOI: 10.1016/j.aap.2006.11.006

Source DB:  PubMed          Journal:  Accid Anal Prev        ISSN: 0001-4575


  2 in total

1.  Challenges in studying statewide pedestrian injuries and drug involvement.

Authors:  Elizabeth D Nesoff; Charles C Branas; Silvia S Martins
Journal:  Inj Epidemiol       Date:  2018-12-03

2.  Pedestrian injury and the built environment: an environmental scan of hotspots.

Authors:  Nadine Schuurman; Jonathan Cinnamon; Valorie A Crooks; S Morad Hameed
Journal:  BMC Public Health       Date:  2009-07-14       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.